secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2024-02-06T23:59:59+00:00
Accession:  0001681622-24-000008
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q1 FY2024 revenue $190M (-8% YoY), GAAP loss $0.01/sh, non-GAAP EPS $0.06
-------------------------------------------------------------------------------

- Revenue $190M, down 8% YoY; Medical segment $140M (-13%), Industrial $50M (+10%).
- GAAP net loss $0.01/diluted share; Non-GAAP EPS $0.06 vs $0.21 in prior year.
- Non-GAAP gross margin 31% (vs 32% YoY); operating margins declined.
- Cash from operations $10M; cash & equivalents $195M, flat vs FY2023 year-end.
- Q2 FY2024 guidance: revenue $195-215M, non-GAAP EPS $0.10-$0.30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/0001681622-24-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000008/vrex-20240206.htm
  HTML page:      https://secwatch.observer/filing/0001681622-24-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer